Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage (LAA) in Patients With Atrial Fibrillation

NCT02105584 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DEVICE: Implantation of LAA closure device

Sponsor

Occlutech International AB